KARYOPHARM THERAPEUTICS INC
KPTI·48576U205·US·Common Stock·Healthcare - Biotechnology-13D/G
KPTI (KARYOPHARM THERAPEUTICS INC) is held by 60 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($18.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($14.9M), GOLDMAN SACHS GROUP INC ($13.9M). Net institutional sentiment: Bullish.
60
Holders
(3 Elite)
$121.3M
Total Value
78% (60)
Consensus
47 buying - 13 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Sep 21, 2026 · Insiders Sep 2, 2026 · Activists Sep 4, 2026 · Congress none
ActivistICIntegrated Core Strategies (US) LLC5.7%Sep 4, 2026
InsiderAKAbate KristinSell $38.38Sep 1, 2026
ActivistCOCommodore Capital LP0.0%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 66
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer